Skip to content
GLP-1 Desk
Menu
Dispatch #356

Eve

Eve is a women's-health-focused GLP-1 telehealth platform — distinctive positioning in a largely gender-neutral market — offering both compounded semaglutide and tirzepatide (including an oral sublingual…

Visit EveAssume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way.
Semaglutide
$195/mo (compounded)
Tirzepatide
$195/mo (compounded)
Coverage
Coverage not published
Brand-name
Yes

Weigh Eve against the full ranked field on the best semaglutide providers board, or line it up against its closest alternatives. Or go one-on-one: Eve vs CoreAge Rx.

Desk Score breakdown

Each of the six scored dimensions. See the methodology.

Price transparency30/100
State access24/100
Molecule range90/100
Onboarding speed70/100
Support responsiveness71/100
Licensing & trust79/100

What the Desk likes

  • Genuinely women's-health-focused — fills a real gap among gender-neutral GLP-1 competitors
  • Both compounded and brand-name FDA-approved options (Wegovy/Ozempic/Mounjaro) on one platform — rare
  • LegitScript Certified with a verifiable ID
  • Publishes the FDA compounded-medication disclaimer
  • Oral sublingual semaglutide offered alongside injectable

Where points come off

  • Full states-served list not disclosed publicly
  • 503A pharmacy partner not named, and 503A vs 503B status not specified
  • Named medical director / clinical leadership not disclosed
  • Corporate legal entity not disclosed
  • Governing law / arbitration venue not stated

The Desk's briefing — C

Best for: Readers who want women's-health GLP-1 with compounded or brand-name access.

Eve ranks #356 of 498 providers scored — see #1, CoreAge Rx on the board.

Related dispatches

Everyone else on the board (18)

Pricing and verification reflect Eve's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on Eve's site. Not medical advice; see our disclosure.

← Back to The Desk